Drug intelligence / Profile preview

piperidolate

Development stage
Unknown
Lead developer
Kyorin Pharmaceutical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Piperidolate is a synthetic small molecule antimuscarinic (anticholinergic) drug used primarily as an antispasmodic agent for the symptomatic treatment of smooth muscle pain and spasms associated with gastrointestinal disorders such as gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary tract dyskinesia. It acts by competitively inhibiting muscarinic acetylcholine receptors at post-ganglionic cholinergic sites in smooth muscle tissue. This blockade reduces acetylcholine-induced contractions in the gastrointestinal tract and other smooth muscles (including uterine muscle), thereby relieving spasms and discomfort. Piperidolate may also have local anesthetic effects similar to cocaine on mucous membranes[1][4][5][6][7][8].

Brand names
Dactil
Other names
1-ethylpiperidin-3-yl 2,2-diphenylacetatepiperidolatopiperidolatumpipéridolatepiperidolat
02

Targets

mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on piperidolate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on piperidolate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call